Vonoprazan fumarate pharmaceutical composition
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JIANGSU HANSOH PHARMA CO LTD
- Publication Date
- 2017-10-03
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of pharmaceutical preparations, specifically, a stable pharmaceutical composition containing vonoprazan fumarate and excipients, and a stabilization method thereof. The pharmaceutical composition of the invention is used for treating and maintaining non-erosive gastroesophageal reflux disease, duodenal ulcer, gastric ulcer, erosive esophagitis and other acid-related diseases. Background technique
[0002] Vonoprazan fumarate (Formula I), the chemical name is 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N -Methylmethylamine fumarate, which belongs to a new type of PPI-potassium ion competitive acid blockers (Potassium-competitive acid blockers, P-CAB), through competitive inhibition of hydrogen ion / potassium ion-ATPase It is a reversible potassium ion antagonist. Compared with the traditional PPI, the acid-suppressing effect of vonoprazan fumarate has nothing to do with the activation of the proton ...